26 Jun 2016
(MENAFN) Global firms among all sectors welcome the Saudi’s “Vision 2030” initiative drawing the plans to achieve a thriving economy and a vibrant society.
Furthermore, among those global healthcare leader is MSD Saudi Arabia, which is also known as Merck in US and Canada.
The company spends close to USD7bn yearly on 18 percent of its sales on research and development, which is one of the highest in the industry.
Accordingly, the main goal for the firm is in solving for unmet medical needs amid its leading R & D products and team.
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more